SCHEMBL6489134

SCHEMBL6489134

CCC(C)OC(=O)OC(=O)OC(C)CC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.42
MAPT P10636 3/20 0.36
TSHR P16473 4/20 0.33
ALDH1A1 P00352 3/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
TBXA2R P21731 1/20 0.33
LMNA P02545 4/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32
CYP2C9 P11712 1/20 0.32
GALR3 O60755 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
FFAR3 O14843 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26412853 0.93 SOAT1 (0.37) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL2980293 0.89 MAPT (0.38) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL2984199 0.89 MAPT (0.38) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL25382868 0.89 MAPT (0.38) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL149834 0.89 MAPT (0.38) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL25380452 0.89 MAPT (0.38) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL11767115 0.89 SOAT1 (0.62) SOAT1MAPTALDH1A1LMNA
SCHEMBL5490241 0.88 MAPT (0.37) SOAT1MAPTTSHRCHRM2CHRM4
SCHEMBL6660470 0.88 ALDH1A1 (0.39) SOAT1MAPTTSHRALDH1A1CHRM2
SCHEMBL2991479 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116375706-B Abamectin sodium key intermediate and preparation method thereof 时森海(杭州)医药科技有限公司 2025-02-14 CN claimed
CN-116375706-A Abamectin sodium key intermediate and preparation method thereof 时森海(杭州)医药科技有限公司 2023-07-04 CN claimed
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS ENEVATE CORPORATION 2020-12-10 US claimed
CN-116693726-B Method for preparing scale inhibitor based on olefin functional polymer 江苏扬农化工集团有限公司 2026-05-12 CN disclosed
CN-119751727-A Ethylene-vinyl alcohol copolymer resin composition and preparation method and application thereof 万华化学集团股份有限公司 2025-04-04 CN disclosed
CN-116375706-B Abamectin sodium key intermediate and preparation method thereof 时森海(杭州)医药科技有限公司 2025-02-14 CN disclosed
CN-118812746-A Methanol-free organic peroxide emulsions 诺力昂化学品国际有限公司 2024-10-22 CN disclosed
CN-109321157-B Adhesive composition for optical film, adhesive layer for optical film, optical film with adhesive layer, and image display device 日东电工株式会社 2024-03-12 CN disclosed
CN-116751324-A Application of functional polymer based on olefin 江苏扬农化工集团有限公司 2023-09-15 CN disclosed
CN-116751323-A Method for preparing electrode slurry by using olefin functional polymer as adhesive 江苏扬农化工集团有限公司 2023-09-15 CN disclosed
CN-116715792-A Method for preparing glass fiber impregnating compound based on multi-olefin functional polymer 江苏扬农化工集团有限公司 2023-09-08 CN disclosed
CN-101889036-B Photochromic curable composition TOKUYAMA CORPROATION 2013-01-02 CN disclosed
EP-2537839-A1 B-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING B-DIHYDROFURAN DERIVING COMPOUND OR B-TETRAHYDROFURAN DERIVING COMPOUND, B -GLYCOSIDE COMPOUND, METHOD FOR PRODUCING B-GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF Nissan Chemical Industries, Ltd. (JP) 2012-12-26 EP disclosed
US-20120322995-A1 beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-12-20 US disclosed
US-6890377-B2 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2005-05-10 US disclosed
US-20040089199-A1 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2004-05-13 US disclosed
US-6486319-B1 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2002-11-26 US disclosed
EP-0871442-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-10-21 EP disclosed
CN-1167760-A Organic peroxide stabilization with beta-dicarbonyl or cyclic alpha-diketone compounds WITCO CORP (US) 1997-12-17 CN disclosed
WO-1997025041-A1 BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS SOST, CA1, DUOX2 SOAT1 1049/4885MAPT 3895/4885TSHR 4386/4885
US-20120322995-A1 beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF DHPS, B4GALT1, STT3A SOAT1 423/4885MAPT 2218/4885TSHR 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.